Erschienen: 23.01.2020 Abbildung von Cornes / McBride | Fast Facts: Biosimilars in Hematology and Oncology | 1. Auflage | 2020 |

Cornes / McBride

Fast Facts: Biosimilars in Hematology and Oncology

Biologics and biosimilars - getting decisions right.

lieferbar (3-5 Tage)

ca. 19,25 €

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen


Buch. Softcover


128 S.

In englischer Sprache

Karger Verlag. ISBN 978-1-912776-21-4

Format (B x L): 14.8 x 21.1 cm

Gewicht: 222 g


Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: . Biologics and the need for biosimilars . Why do we need biosimilars? . How is the quality of biosimilar medicines assured? . Legal issues . Switching, interchangeability and extrapolation . Safety and pharmacovigilant . Global issues . Formulary considerations: pharmacy issues . Formulary considerations: supportive care biosimilars . Formulary considerations: therapeutic anti-cancer biosimilars . Communication and awareness

Top-Produkte dieser Kategorie

Unsere Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte


  • Rezensionen

    Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...